Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data.

Baker CL, Zou KH, Su J.

Int J Chron Obstruct Pulmon Dis. 2014 May 3;9:431-9. doi: 10.2147/COPD.S59322. eCollection 2014.

2.

Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study.

Wurst KE, St Laurent S, Mullerova H, Davis KJ.

Int J Chron Obstruct Pulmon Dis. 2014 Sep 25;9:1021-31. doi: 10.2147/COPD.S58258. eCollection 2014.

3.

Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.

Fitch K, Iwasaki K, Pyenson B, Plauschinat C, Zhang J.

Curr Med Res Opin. 2011 Jul;27(7):1425-9. doi: 10.1185/03007995.2011.583230. Epub 2011 May 23.

PMID:
21599554
4.

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.

Asche CV, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, Young D.

Int J Chron Obstruct Pulmon Dis. 2012;7:201-9. doi: 10.2147/COPD.S25805. Epub 2012 Mar 15.

5.

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.

Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K.

Int J Chron Obstruct Pulmon Dis. 2014 Aug 27;9:889-904. doi: 10.2147/COPD.S62750. eCollection 2014.

6.

Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.

Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.

Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.

PMID:
19948302
8.

Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians.

Salinas GD, Williamson JC, Kalhan R, Thomashow B, Scheckermann JL, Walsh J, Abdolrasulnia M, Foster JA.

Int J Chron Obstruct Pulmon Dis. 2011;6:171-9. doi: 10.2147/COPD.S16396. Epub 2011 Feb 28.

9.

Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States.

Diette GB, Dalal AA, D'Souza AO, Lunacsek OE, Nagar SP.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 24;10:415-22. doi: 10.2147/COPD.S75034. eCollection 2015.

10.
11.

Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.

Singh MP.

Int J Chron Obstruct Pulmon Dis. 2013;8:613-9. doi: 10.2147/COPD.S53707. Epub 2013 Dec 9.

12.

Respiratory-related medical expenditure and inpatient utilisation among COPD patients receiving long-acting bronchodilator therapy.

Cao Z, Zou KH, Baker CL, Su J, Paulose-Ram R, Durden E, Shi N, Shah H.

J Med Econ. 2011;14(2):147-58. doi: 10.3111/13696998.2011.552582. Epub 2011 Feb 2.

PMID:
21288057
13.

Subutilization of COPD guidelines in primary care: a pilot study.

Laniado-Laborín R, Rendón A, Alcantar-Schramm JM, Cazares-Adame R, Bauerle O.

J Prim Care Community Health. 2013 Jul 1;4(3):172-6. doi: 10.1177/2150131913475817. Epub 2013 Jan 31.

PMID:
23799703
14.

Risk assessment of readmissions following an initial COPD-related hospitalization.

Baker CL, Zou KH, Su J.

Int J Chron Obstruct Pulmon Dis. 2013;8:551-9. doi: 10.2147/COPD.S51507. Epub 2013 Nov 12.

15.

Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.

Chavez PC, Shokar NK.

COPD. 2009 Dec;6(6):446-51. doi: 10.3109/15412550903341455.

PMID:
19938968
16.
17.

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW.

Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455.

18.

Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.

Franssen FM, Spruit MA, Wouters EF.

Int J Chron Obstruct Pulmon Dis. 2011;6:493-501. doi: 10.2147/COPD.S24443. Epub 2011 Sep 26.

19.

Use and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary disease.

Lindenauer PK, Shieh MS, Pekow PS, Stefan MS.

Ann Am Thorac Soc. 2014 Oct;11(8):1186-94. doi: 10.1513/AnnalsATS.201407-311OC.

20.

Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.

Bollu V, Ernst FR, Karafilidis J, Rajagopalan K, Robinson SB, Braman SS.

Int J Chron Obstruct Pulmon Dis. 2013;8:631-9. doi: 10.2147/COPD.S52557. Epub 2013 Dec 5.

Items per page

Supplemental Content

Write to the Help Desk